How to Apply
*** Please consult the Frequently Asked Questions before contacting HEI staff. Thank you! ***
LETTER OF INTENT
HEI requires applicants to send a two- or three-page Letters of Intent to provide information on the likely response to the RFA and to organize the application review process. It should include a synopsis of the project and study objectives, indicating the hypotheses to be addressed, qualifications of the team listing key members of the research team and their roles in the project, a list of all participating institutions, and access to relevant data (if applicable). An estimated total budget and study duration should be provided, choosing from the 2 options provided (i.e., a one-year or two-year study). A template is provided below.
In addition, brief biosketches (maximum 2 pages per person) of the principal investigator and key co-investigator(s) should be provided. Applicants can use HEI form F-8 or another format, as long as each biosketch is no longer than 2 pages. The letter and biosketches should be turned into a combined PDF before submitting. Confidential or proprietary information on methodologic details should not be included in the Letter of Intent.
Deadline for Letters of Intent
Letters of intent should be submitted by e‐mail in PDF format to firstname.lastname@example.org (subject line: PI last name RFA 20-1B Letter of Intent) no later than JUNE 8, 2020, with a copy to Ms. Lissa McBurney (email@example.com). HEI will acknowledge receipt of the application.
All letters of intent received by June 8 will be considered. Researchers who miss the deadline for submitting a letter of intent should contact HEI as soon as possible to determine whether their application can still be considered.
Letters of Intent Evaluation Process
Letters of intent will be reviewed by the Research Committee at the end of June to determine relevance of the proposed research to the objectives of the RFA. If a large number of letters is received, it is at the discretion of the Committee to rank applications based on scientific merit and responsiveness to the RFA and invite a limited number of full applications. Applicants will be informed whether or not to submit a full application by early July. HEI may contact the applicant to advise him or her about how to make the application more responsive to the specific objectives of the RFA. For questions contact HEI at firstname.lastname@example.org.
FULL APPLICATION (by invitation only)
Investigators invited to submit a full application should use the forms provided below and consult the Instructions for Completing the Application. [Note that updated forms will be posted later.] Please note that the required font size is 11 point with 1‐inch margins. The application forms should be turned into a combined PDF with appropriate bookmarks before submitting. Applicants should familiarize themselves with HEI’s study oversight and review procedures, which are more involving that a typical NIH proposal, see www.healtheffects.org/research/investigators/commitments.
Deadline for Full Applications
Invited Full Applications for RFA 20-1B should be submitted to email@example.com (subject line: Your Name RFA 20-1A Full application) no later than JANUARY 6, 2021. The application should be in PDF format with a maximum file size of 20 MB. After submission, please notify Ms. Lissa McBurney (firstname.lastname@example.org) of your submission; do not attach the PDF documents to this email. HEI will acknowledge receipt of the application. Applicants will be notified about the funding decision by mid March, 2021.